Therapix Biosciences Ltd. is a clinical-stage pharmaceutical company specializing in cannabinoid pharmaceuticals development. Led by a seasoned team of executives and scientists, the company is focused on expanding its portfolio of technologies and assets. The company’s drug development programs are based on tetrahydrocannabinol (THC) and non-psychoactive cannabidiol (CBD). The programs include THX-110 for treating Tourette syndrome and obstructive sleep apnea, THX-160 for pain relief, and THX-210 for treating autism spectrum disorder and epilepsy.
Therapix Biosciences Ltd.'s ticker is TRPX
The company's shares trade on the NASDAQ stock exchange
They are based in Givatayim, Israel
There are 11-50 employees working at Therapix Biosciences Ltd.
It is https://therapixbio.com/
Therapix Biosciences Ltd. is in the Healthcare sector
Therapix Biosciences Ltd. is in the Biotechnology industry
The following five companies are Therapix Biosciences Ltd.'s industry peers: